Is the business good?
How good a business is RVTY?
Revvity earns 3.0% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
3.0%
Return on invested capital · cost of capital 9.0% · 6.0 points below what the capital costs: growth destroys value
- Operating margin
- 12%
Operating margin · Diagnostics & Research median 7.1% · 12 months to Q2 2026
- Cash conversion
- 2.35×
Cash conversion · 1.76× a year ago · every dollar of reported profit arrived as cash, and more
- Share count, year on year
- −5.0%
Share count, year on year · bought back, each share owns more of the company
| Year | Operating margin |
|---|---|
| FY2020 | 23% |
| FY2021 | 33% |
| FY2022 | 22% |
| FY2023 | 11% |
| FY2024 | 13% |
| FY2025 | 12% |
Details›
- Operating margin12 months to Q2 2026
- 12%
- Net margin12 months to Q2 2026
- 8.2%
- Free cash flow margin
- 19%
- R&D as % of revenue
- 7.4%
- Revenue, trailing twelve months
- $2.91B
- Free cash flow, trailing twelve months
- $558M
- Net income, trailing twelve months
- $238M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 3.0%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Diagnostics & Research
Ranks #26 of 29 by Smart Score